New drug molidustat tracked in Real-World kidney anemia study
NCT ID NCT04899661
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study follows over 1,000 Japanese patients with renal anemia (low red blood cells due to kidney disease) who are taking Molidustat. Researchers are monitoring safety issues like blood clots, high blood pressure, and heart problems, as well as whether the drug boosts red blood cell counts. The goal is to see how well the drug works and what side effects occur in everyday medical practice over up to 2 years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL ANEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Many facilities
Multiple Locations, Japan
Conditions
Explore the condition pages connected to this study.